CD8 T cells have a critical function in response to immune checkpoint blockade but tumor-infiltrating lymphocytes (TILs), including CD8 T cells, express high levels of immune checkpoint receptors, e.g., PD-1, that can suppress cytotoxic T cell effector function. The gene discussed is CD8A; the disease is neoplasm.